|
1
|
|
2,632
|
+19
|
+0.7%
|
US$1692億
|
|
|
2
|
|
2,120
|
-65
|
-3%
|
US$1101億
|
|
|
3
|
|
1,626
|
+21
|
+1%
|
US$213億
|
|
|
4
|
Regeneron Pharmaceuticals
|
1,341
|
-60
|
-4%
|
US$571億
|
|
|
5
|
|
1,137
|
+61
|
+6%
|
US$346億
|
|
|
6
|
|
942
|
+90
|
+11%
|
US$275億
|
|
|
7
|
|
794
|
0
|
0%
|
US$401億
|
|
|
8
|
|
601
|
+115
|
+24%
|
US$200億
|
|
|
9
|
Charles River Laboratories
|
571
|
+10
|
+2%
|
US$129億
|
|
|
10
|
|
545
|
+41
|
+8%
|
US$127億
|
|
|
11
|
|
524
|
+32
|
+7%
|
US$41.6億
|
|
|
12
|
|
516
|
+18
|
+4%
|
US$143億
|
|
|
13
|
|
502
|
+64
|
+15%
|
US$97.3億
|
|
|
14
|
|
476
|
+13
|
+3%
|
US$144億
|
|
|
15
|
|
423
|
+55
|
+15%
|
US$111億
|
|
|
16
|
|
418
|
+72
|
+21%
|
US$85.2億
|
|
|
17
|
|
394
|
+61
|
+18%
|
US$49.2億
|
|
|
18
|
|
382
|
+30
|
+9%
|
US$82億
|
|
|
19
|
|
375
|
+9
|
+2%
|
US$26億
|
|
|
20
|
|
370
|
+36
|
+11%
|
US$52.3億
|
|
|
21
|
|
338
|
-9
|
-3%
|
US$56.8億
|
|
|
22
|
|
337
|
+56
|
+20%
|
US$78.5億
|
|
|
23
|
|
328
|
+24
|
+8%
|
US$24.4億
|
|
|
24
|
|
324
|
-21
|
-6%
|
US$19.3億
|
|
|
25
|
|
320
|
+40
|
+14%
|
US$24.7億
|
|
